Animal Therapeutics and Diagnostics

Table of Contents

• Animal Therapeutics and Diagnostics

Chapter- 1: SUMMARY

• SUMMARY TABLE TOTAL ANIMAL THERAPEUTIC AND DIAGNOSTIC MARKET BY MAJOR SEGMENT, THROUGH 2013 ($ MILLIONS)
• SUMMARY FIGURE TOTAL ANIMAL THERAPEUTIC AND DIAGNOSTIC MARKET BY MAJOR SEGMENT, 2006-2013 ($ MILLIONS)
• LEADING PRODUCTS AND MANUFACTURERS

Chapter- 2: INDUSTRY OVERVIEW

• ANIMAL ANATOMY AND PHYSIOLOGY
• ANIMAL ANATOMY AND PHYSIOLOGY (CONTINUED)
• REPRODUCTIVE SYSTEM
  • TABLE 1 GESTATION PERIODS OF SELECT COMMON SPECIES
• AVIAN ANATOMY
• Avian Anatomy (Continued)
• Avian Anatomy (Continued)
• ANIMAL POPULATIONS
• COMPANION ANIMALS
  • TABLE 2 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOR 2007, UNITED STATES (THOUSANDS)
• FARM ANIMALS
  • TABLE 3 REPORTED 2005 AND ESTIMATED 2006* POPULATION OF FARM ANIMALS, UNITED STATES (MILLIONS)
  • TABLE 4 LIFESPAN OF COMMON PET AVIAN SPECIES
  • TABLE 4 (CONTINUED)
• COMPANION ANIMAL DISEASES
• INFECTIOUS DISEASES
• Viruses
• Adenovirus
• Avian Influenza
• Coronavirus
• Distemper
• Eastern Equine Encephalitis
• Equine Viral Arteritis
• Feline Calicivirus and Feline Herpes Virus
• Feline Immunosuppressive Virus
• Feline Infectious Peritonitis Virus
• Feline Leukemia Virus
• Infectious Hepatitis
• Internal Papillomatosis of Parrots
• Newcastle Disease
• Pacheco' s Disease
• Parainfluenza Virus
• Paramyxoviruses
• Parvovirus
• Polyomavirus
• Poxviruses
• Psittacine Beak and Feather Disease
• Rabies
• Reovirus
• West Nile Virus
• Bacteria
• Black Tongue
• Bordetella
• Brucellosis
• Campylobacteriosis
• Chlamydia
• Leptospirosis
• Lyme Disease
• Q-Fever
• Respiratory Mycoplasmosis
• Spirochaetaceae
• Tetanus
• ALLERGY AND INFLAMMATORY DISEASES
• Allergies
• Arthritis
• Asthma
• Dermatitis
• Eosinophilic Granuloma Complex
• Gout
• Inflammatory Bowel Disease
• METABOLIC DISEASES
• Cushing' s Syndrome
• Diabetes Mellitus
• Thyroid Disease
• Pancreatitis
• Metabolic Bone Disease in Birds
• PARASITIC DISEASES
• Ear Mites
• Fleas
• Heartworm
• Hemobartonellosis
• Feline Scabies
• Lice
• Sarcoptic Mange
• Worms
• Urinary Diseases
• Glomerulonephritis
• Feline Lower Urinary Tract Disease
• Other Diseases
• Equine Protozoal Myelitis
• Leptospirosis and Equine Recurrent Uveitis
• Neoplastic Disease
• Neoplastic Disease (Continued)
• Heart Disease
• FOOD ANIMAL DISEASES
• INFECTIOUS DISEASES
• Viruses and Prions
• Avian Pneumovirus
• Bovine Spongiform Encephalopathy
• Bovine Viral Diarrhea
• Bovine Viral Diarrhea (Continued)
• Classical Swine Fever
• Foot and Mouth Disease
• Furunculosis
• Infectious Pancreatic Necrosis
• Marek' s Disease
• Pathogenic Avian Influenza
• Q-Fever
• Vesicular Stomatitis
• Bacteria
• Anthrax
• Blackleg
• Conjunctivitis
• Tetanus
• OTHER DISEASES OF FOOD ANIMALS
• Heartwater
• Pneumonia
• Texas Cattle Fever
• ZOONOTIC DISEASES
• ZOONOTIC DISEASES (CONTINUED)
  • TABLE 5 COMMON EXAMPLES OF ZOONOTIC DISEASES
• ISSUES AFFECTING THE MARKET
• ANTIBIOTIC USE AND RESISTANCE IN FOOD ANIMALS
• Therapeutic Use
  • TABLE 6 APPROVED ANTIBIOTICS AND SULFONAMIDES USED IN DIARY AND BEEF CATTLE PRODUCTION IN U.S.
  • TABLE 7 APPROVED ANTIBIOTICS USED IN HOG PRODUCTION IN U.S.
  • TABLE 8 APPROVED ANTIBIOTICS USED IN SHEEP PRODUCTION IN U.S.
  • TABLE 9 APPROVED ANTIBIOTICS USED IN CHICKEN AND TURKEY PRODUCTION IN U.S.
• Resistance
• Human Side-Effects
• Microbial Ecology
• PROBIOTICS
• LEGAL AND REGULATORY ISSUES
• Minimally and Highly Regulated Products
• Animal Drug User Fee Act of 2003
• ANIMAL HEALTH INSURANCE
• Animal Health Insurance (Continued)
• SPRAY-ON DRUGS
• BIOTECHNOLOGY
• ANIMAL OBESITY
• Causes
• Weight Reduction
• NEW TRENDS IN AGING DISEASES
• COMPANION PET OWNERSHIP
• DEMAND IN THE VETERINARY SERVICE INDUSTRY
  • TABLE 10 ESTIMATED NUMBER OF VETERINARIAN PRACTICES IN THE UNITED STATES BY TYPE OF PRACTICE, 2007
• LIFE CYCLE APPROACH
• INTERNATIONAL ISSUES AND TRENDS
  • TABLE 11 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOR 2005, JAPAN AND AUSTRALIA (MILLIONS)
  • TABLE 12 ESTIMATED POPULATIONS OF FARM ANIMALS FOR 2004, BRAZIL (MILLIONS)

Chapter- 3: ANIMAL VACCINES

• OVERVIEW
• PRODUCT DESCRIPTION
• ACTIVE IMMUNITY
• PASSIVE IMMUNITY
• OTHER TYPES
• TARGET SPECIES AND PROVIDERS
  • TABLE 13 VACCINES BY TARGET SPECIES AND PROVIDERS
  • TABLE 13 (CONTINUED)
  • TABLE 13 (CONTINUED)
  • TABLE 13 (CONTINUED)
  • TABLE 13 (CONTINUED)
  • TABLE 13 (CONTINUED)
• COMPANION ANIMAL VACCINES
• BOEHRINGER INGELHEIM
• FORT DODGE
• HESKA
• MERIAL
• NOVARTIS
• SCHERING-PLOUGH
• FOOD ANIMAL VACCINES
• ALPHARMA
• BAYER
• BOEHRINGER INGELHEIM
• FORT DODGE
• INTERVET
• MERIAL
• NOVARTIS
• PFIZER
• SCHERING-PLOUGH
• Poultry
• Poultry (Continued)
• Poultry (Continued)
• Poultry (Continued)
• Cattle and Sheep
• Swine
• Rabies
• Fish
• MARKET ANALYSIS AND CONCLUSIONS
• MARKETS BY USE OR APPLICATION
  • TABLE 14 GLOBAL MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 1 GOBAL MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, 2006-2013 ($ MILLIONS)
• VACCINE MARKET BY TYPE
  • TABLE 15 ESTIMATED GLOBAL REVENUES FOR ANIMAL VACCINES BY TYPE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 2 ESTIMATED GLOBAL REVENUES FOR ANIMAL VACCINES BY TYPE, 2006-2013 ($ MILLIONS)
• MARKETS BY GEOGRAPHICAL REGION
  • TABLE 16 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION, 2007 (%/$ MILLIONS)
  • FIGURE 3 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION, 2007 (%)
• COMPETITIVE SUMMARY
• Intervet
• Schering-Plough
• Fort Dodge
• Other Companies
  • TABLE 17 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE, 2007 (%/$ MILLIONS)
  • FIGURE 4 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE, 2007 (%)

Chapter- 4: ANIMAL PHARMACEUTICAL PRODUCTS

• OVERVIEW
• PRODUCT DESCRIPTION
• ALLERGY AND RESPIRATORY DRUGS
• TARGET SPECIES AND PROVIDERS
  • TABLE 18 ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES AND PROVIDERS
• ANTI-INFECTIVES AND ANTIFUNGALS
• Bayer
• Boehringer Ingelheim
• Elanco
• Esteve
• Fort Dodge
• ECO
• Novartis
• Pfizer
• Schering-Plough
• Target Species and Providers
  • TABLE 19 ANTI-INFECTIVES BY TARGET SPECIES AND PROVIDERS
  • TABLE 19 (CONTINUED)
  • TABLE 19 (CONTINUED)
• ANTI-INFLAMMATORIES AND ANALGESICS
• Bayer
• Boehringer Ingelheim
• Elanco
• Esteve
• Fort Dodge
• Bioniche
• Novartis
• Pfizer
• Schering-Plough
• Luitpold Animal Health
• Target Species and Providers
  • TABLE 20 ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES AND PROVIDERS
• METABOLIC DRUGS
• Target Species and Providers
  • TABLE 21 METABOLIC DRUGS BY TARGET SPECIES AND PROVIDERS
• PARASITICIDES
• Bayer
• Boehringer-Ingelheim
• Esteve
• Fort Dodge
• IDEXX
• ECO
• Merial
• Novartis
• Pfizer
• Schering-Plough
• Virbac
• Target Species and Providers
  • TABLE 22 PARASITICIDES BY TARGET SPECIES AND PROVIDERS
  • TABLE 22 (CONTINUED)
• OTHER PHARMACEUTICALS
• Esteve
• Merial
• Schering-Plough
• Dental
• Virbac
• Biopure
• Novartis
• Target Species and Providers
  • TABLE 23 OTHER PHARMACEUTICALS BY TARGET SPECIES AND PROVIDERS
• MARKET ANALYSIS AND CONCLUSIONS
• MARKETS BY USE OR APPLICATION
• Allergy and Respiratory Market
  • TABLE 24 GLOBAL MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 5 GLOBAL MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE, 2006-2013 ($ MILLIONS)
• Anti-Infective Market
  • TABLE 25 GLOBAL MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 6 GLOBAL MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, 2006-2013 ($ MILLIONS)
• Anti-Inflammatory Market
  • TABLE 26 GLOBAL MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND ANALGESICS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 7 GLOBAL MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND ANALGESICS BY USE, 2006-2013 ($ MILLIONS)
• Metabolic Drug Market
  • TABLE 27 GLOBAL MARKET ANALYSIS FOR METABOLIC DRUGS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 8 GLOBAL MARKET ANALYSIS FOR METABOLIC DRUGS BY USE, 2006-2013 ($ MILLIONS)
• Parasiticide Market
  • TABLE 28 GLOBAL MARKET ANALYSIS FOR PARASITICIDES BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 9 GLOBAL MARKET ANALYSIS FOR PARASITICIDES BY USE, 2006-2013 ($ MILLIONS)
• Other Pharmaceuticals
  • TABLE 29 GLOBAL MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 10 GLOBAL MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY USE, 2006-2013 ($ MILLIONS)
• TOTAL PHARMACEUTICALS
  • TABLE 30 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 11 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY USE, 2006-2013 ($ MILLIONS)
• Summary-Pharmaceutical Markets
  • TABLE 31 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 12 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, 2006-2013 ($ MILLIONS)
• MARKETS BY GEOGRAPHICAL REGION
  • TABLE 32 DISTRIBUTION OF REVENUES FOR ANIMAL PHARMACEUTICALS BY WORLD REGION, 2007 (%)
  • FIGURE 13 DISTRIBUTION OF REVENUES FOR ANIMAL PHARMACEUTICALS BY WORLD REGION, 2007 (%)
• COMPETITIVE SUMMARY
  • TABLE 33 COMPETITIVE SUMMARY FOR ANIMAL PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES, 2007 (%/$ MILLIONS)
  • FIGURE 14 COMPETITIVE SUMMARY FOR ANIMAL PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES, 2007 (%)

Chapter- 5: ANIMAL FEED ADDITIVES

• OVERVIEW
• PRODUCT DESCRIPTION
• AMINO ACIDS
• TARGET SPECIES AND PROVIDERS
  • TABLE 34 AMINO ACIDS BY TARGET SPECIES AND PROVIDERS
• MEDICINAL ADDITIVES
• Alpharma
• Elanco
• ECO
• Novartis
• Merial
• Pfizer
• Schering-Plough
• Boehringer Ingelheim
• Target Species and Providers
  • TABLE 35 MEDICINAL ADDITIVES BY TARGET SPECIES AND PROVIDERS
• NUTRITIONAL SUPPLEMENTS
• NUTRITIONAL SUPPLEMENTS (CONTINUED)
• TARGET SPECIES AND PROVIDERS
  • TABLE 36 NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES AND PROVIDERS
• VITAMINS AND MINERALS
• BEAPHAR
• ESTEVE
• ADISSEO
• MOSAIC (FORMERLY IMC GLOBAL)
• DSM NUTRITIONAL
• SCHERING-PLOUGH
• CHURCH & DWIGHT CO.
• VIRBAC
• TARGET SPECIES AND PROVIDERS
  • TABLE 37 VITAMINS AND MINERALS BY TARGET SPECIES AND PROVIDERS
  • TABLE 37 (CONTINUED)
• MARKET ANALYSIS AND CONCLUSION
• MARKETS BY USE OR APPLICATION
• Amino Acid Market
  • TABLE 38 GLOBAL MARKET ANALYSIS FOR AMINO ACIDS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 15 MARKET ANALYSIS FOR AMINO ACIDS BY USE, 2006-2013 ($ MILLIONS)
• Medicinal Feed Additive Market
  • TABLE 39 GLOBAL MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 16 GLOBAL MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES BY USE, 2006-2013 ($ MILLIONS)
• Nutritional Supplement Market
  • TABLE 40 GLOBAL MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 17 GLOBAL MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS BY USE, 2006-2013 ($ MILLIONS)
• Vitamin and Mineral Market
  • TABLE 41 GLOBAL MARKET ANALYSIS FOR VITAMINS AND MINERALS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 18 GLOBAL MARKET ANALYSIS FOR VITAMINS AND MINERALS BY USE, 2006-2013 ($ MILLIONS)
• Total Feed Additive Market
  • TABLE 42 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 19 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY USE, 2006-2013 ($ MILLIONS)
• FEED ADDITIVE MARKET BY TYPE
  • TABLE 43 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 20 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, 2006-2013 ($ MILLIONS)
• MARKETS BY GEOGRAPHICAL REGION
  • TABLE 44 DISTRIBUTION OF REVENUES FOR ANIMAL FEED ADDITIVES BY WORLD REGION, 2007 (%/$ MILLIONS)
  • FIGURE 21 DISTRIBUTION OF REVENUES FOR ANIMAL FEED ADDITIVES BY WORLD REGION, 2007 (%)
• COMPETITIVE SUMMARY
  • TABLE 45 COMPETITIVE SUMMARY FOR ANIMAL FEED ADDITIVES BY COMPETITOR REVENUES, 2007 (%/$ MILLIONS)
  • FIGURE 22 COMPETITIVE SUMMARY FOR ANIMAL FEED ADDITIVES BY COMPETITOR REVENUES, 2007 (%)

Chapter- 6: ANIMAL DIAGNOSTICS

• OVERVIEW
• PRODUCT DESCRIPTION
• HESKA
• IDEXX
• SNAP
• PETCHEK
• DIASYSTEMS
• HERDCHEK
• FLOCKCHEK
• Guildhay and Svanovir
• SCHERING-PLOUGH
• SYNBIOTICS
• TARGET SPECIES AND PROVIDERS
  • TABLE 46 DIAGNOSTICS BY TARGET SPECIES AND PROVIDERS
  • TABLE 46 (CONTINUED)
• MARKET ANALYSIS AND CONCLUSION
• MARKETS BY USE OR APPLICATION
  • TABLE 47 GLOBAL MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS PRODUCTS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 23 GLOBAL MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS BY USE, 2006-2013 ($ MILLIONS)
• DIAGNOSTIC MARKET BY TYPE
  • TABLE 48 ESTIMATED REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 24 ESTIMATED REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, 2006-2013 ($ MILLIONS)
• MARKETS BY GEOGRAPHICAL REGION
  • TABLE 49 DISTRIBUTION OF REVENUES FOR ANIMAL DIAGNOSTICS BY WORLD REGION, 2007 (%/$ MILLIONS)
  • FIGURE 25 DISTRIBUTION OF REVENUES FOR ANIMAL DIAGNOSTICS BY WORLD REGION, 2007 (%)
• COMPETITIVE SUMMARY
  • TABLE 50 COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS BY COMPETITOR REVENUES, 2007 (%/$ MILLIONS)
  • FIGURE 26 COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS BY COMPETITOR REVENUES, 2007 (%)

Chapter- 7: MARKET SUMMARY

• TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTIC MARKET ANALYSIS
  • TABLE 51 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, THROUGH 2013 ($ MILLIONS)
  • FIGURE 27 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY TYPE, THROUGH 2013 ($ MILLIONS)
  • TABLE 52 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 28 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE, 2006-2013 ($ MILLIONS)
• INDUSTRY PARTICIPANTS BY TYPE
  • TABLE 53 MAJOR INDUSTRY PARTICIPANTS BY ANIMAL PRODUCT TYPE
• TOTAL COMPETITIVE ANALYSIS
  • TABLE 54 TOTAL COMPETITIVE MARKET SHARE FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER REVENUES, 2007 (%/$ MILLIONS)
  • FIGURE 29 TOTAL COMPETITIVE SUMMARY FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY COMPETITOR REVENUES, 2007 (%)

Chapter- 8: COMPANY PROFILES

• COMPANY PROFILES
• ADISSEO FRANCE S.A.S
• ALPHARMA, INC.
• BASF ANIMAL NUTRITION (BASF AG)
• BAYER ANIMAL HEALTH
• BOEHRINGER INGELHEIM CORP.
• DSM NUTRITIONAL PRODUCTS
• ELANCO ANIMAL HEALTH
• EVONIK INDUSTRIES
• FORT DODGE ANIMAL HEALTH
• HESKA CORP.
• IDEXX LABORATORIES, INC.
• INTERVET INTERNATIONAL BV
• IVX ANIMAL HEALTH, INC.
• MERIAL ANIMAL HEALTH, LTD.
• MOSAIC
• NOVARTIS ANIMAL HEALTH, INC.
• NOVARTIS AG
• NOVUS INTERNATIONAL, INC.
• PFIZER ANIMAL HEALTH
• SCHERING-PLOUGH ANIMAL HEALTH
• SCHERING-PLOUGH CORP.
• VIRBAC SA
• VIRBAC SA (CONTINUED)
• APPENDIX I: LEADING MANUFACTURES AND AFFILIATED COMPANIES
• ACRUX, LTD.
• ADISSEO FRANCE S.A.S.
• AJINOMOTO CO., LTD.
• AKZO NOBEL N.V.
• ALPHARMA, INC.
• BASF AG
• BASF ANIMAL NUTRITION
• BAYER AG
• BAYER HEALTHCARE, LLC
• BEAPHAR B.V.
• BEN VENUE LABORATORIES, INC.
• BOEHRINGER INGELHEIM CHEMICALS, INC.
• BOEHRINGER INGELHEIM CORP.
• BOEHRINGER INGELHEIM GMBH
• BOEHRINGER INGELHEIM VETMEDICA, INC.
• DSM
• DSM NUTRITIONAL PRODUCTS
• ECO ANIMAL HEALTH
• ELANCO ANIMAL HEALTH
• ELI LILLY & CO.
• ESTEVE
• EVONIK DEGUSSA GMBH
• FORT DODGE ANIMAL HEALTH
• HESKA CORP.
• IDEXX LABORATORIES, INC.
• INTERVET INTERNATIONAL BV
• LUITPOLD ANIMAL HEALTH
• MOSAIC
• MERIAL ANIMAL HEALTH, LTD.
• NOVARTIS AG
• NOVARTIS ANIMAL HEALTH, INC.
• NOVARTIS ANIMAL VACCINES, INC.
• NOVUS INTERNATIONAL, INC.
• PFIZER ANIMAL HEALTH
• PFIZER, INC.
• ROXANE LABORATORIES, INC.
• SCHERING-PLOUGH ANIMAL HEALTH
• SCHERING-PLOUGH CORP.
• SYNBIOTICS CORP.
• VIRBAC S.A.
• WYETH

Chapter- 9: APPENDIX II: RELEVANT ASSOCIATIONS AND ORGANIZATIONS

• AMERICAN ASSOCIATION OF FELINE PRACTITIONERS
• AMERICAN VETERINARY MEDICAL ASSOCIATION
• CANADIAN VETERINARY MEDICAL ASSOCIATION
• UNITED STATES DEPARTMENT OF AGRICULTURE
• UNITED STATES FOOD AND DRUG ADMINISTRATION